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Several variants resistant to 1.8 x 10-4 M DL-methotrexate (MTX) have been
isolated from the human cell lines HeLa BU25 and VA2-B by exposing them to
progressively increasing concentrations of the drug. A striking variability of
phenotype and chromosome constitution was observed among the different
variants. All resistant cell lines exhibited a greatly increased dihydrofolic acid
reductase (DHFR) activity and DHFR content; however, the DHFR activity
levels varied considerably among the variants, ranging between about 35 and 275
times the parental level. In the absence of selective pressure, the increased DHFR
activity was unstable, and in all cell lines but one was completely lost over a
period ranging in different variants between 25 and 200 days. The MTX-resistant
cell lines showed anomalies in their chromosome constitution, which involved the
occurrence of a duplicated set of chromosomes in most cells of some of the
variants and the presence of double minute chromosomes in all cell lines. An
analysis of the correlation of loss of double minute chromosomes and loss of
DHFR activity in the absence of MTX has given results consistent with the idea
that the double-minute chromosomes contain amplified DHFR genes. However,
the most significant finding is that, in contrast to what has been reported in the
mouse system, the recognizable double-minute chromosomes varied greatly in
number in different variants without any relationship to either the level ofDHFR
activity or the degree of instability of MTX resistance in the absence of selective
pressure. These and other observations point to the occurrence in the human
MTX-resistant variants of another set of DHFR genes, representing a varied
proportion of the total, which is associated with the regular chromosomes, and
which may be unstable in the absence of selective pressure.
One of the most striking examples of the
plasticity of the genome in animal cells is provid-
ed by the selective amplification of the genes
coding for proteins with binding specificity for
certain metabolic inhibitors or other harmful
chemicals, as demonstrated in cultured mamma-
lian cells resistant to such agents (1, 5, 29). The
best-studied case of this nature is the dihydrofo-
lic acid reductase (DHFR) gene amplification in
mammalian cells resistant to amethopterin
(methotrexate, MTX) (1). In several human and
experimental tumors and in cultured mouse and
hamster cell lines, the development of the resist-
ance to MTX has been found to be due to an
increased cell content, up to several hundred-
fold, of the enzyme (6, 8, 10-12, 15, 22, 26, 27,
30). In cultured mammalian cell lines, the in-
creased enzyme level has been shown to result
from an increased rate of synthesis (2, 16), due
to a selective amplification of the DHFR genes
(1, 10, 23, 26) and to a parallel increase in the
amount of DHFR mRNA (1, 9, 18, 23).
The biochemical investigations mentioned
above have all been carried out in MTX-resis-
tant cell lines of mouse or hamster origin. Re-
cently, several MTX-resistant cell variants have
been isolated in this laboratory from two differ-
ent human cell lines, HeLa BU25 and VA,-B;
furthermore, the DHFRs have been isolated
from HeLa BU25 cells and from two of the
MTX-resistant derivatives and found to be indis-
tinguishable in their physical and enzymatic
properties (25). In this paper, we report that the
human MTX-resistant cell lines isolated here
exhibit a striking variability in phenotypic prop-
erties and chromosome constitution, even
among sublines. Most significantly, they contain
a highly variable number of double minute chro-
mosomes which is not correlated with either the
level or the stability of their resistance to MTX.
MATERIALS AND METHODS
Materials. Dihydrofolic acid and NADPH were ob-
tained from Sigma Chemical Co. The MTX used as a
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selective agent for the drug-resistant variants was the
DL-form from Sigma (consisting of -50o L-form).
Cel lines and methods of growth. The human cell line
HeLa BU25, a mutant subline of HeLa S3 deficient in
thymidine kinase activity (19), kindly provided by S.
Kit, was grown in petri dishes in Eagle medium
supplemented with 10%o calf serum in the absence or
presence of 25 ,ug of bromodeoxyuridine (BUdR) per
ml. The human cell line VA2-B, an azaguanine-resist-
ant subclone of the simian virus 40-transformed line
WI-18-VA2 (28), was grown in petri dishes in Eagle
medium supplemented with 10%o calf serum and 3 ,ug
of 8-azaguanine per ml. The MTX-resistant variants of
these two cell lines were grown in the media described
above supplemented with l1o extensively dialyzed
calf serum and various concentrations of DL-MTX as
specified below.
Chromosome analysis. Cells were arrested in meta-
phase by treatment with 0.05 p.g of colchicine per ml
for 3 to 5 h. Karyotype analysis was performed as
described previously (24).
Cell extraction preparation and enzyme assay. When
a cell extract had to be prepared for enzyme assay, the
cells were grown in the absence of MTX for 7 days
before harvesting. The preparation of cell extracts and
the enzyme assays were carried out essentially as
described by Frearson et al. (13), except that in the
enzyme assay the concentration of dihydrofolic acid
was doubled. One unit of enzyme activity was defined
as the amount of enzyme required to reduce 1 nmol of
dihydrofolic acid in 15 min at 21°C.
Electrophoretic analysis. Electrophoresis of the cell
extracts was carried out by using the Laemmli sodium
dodecyl sulfate-polyacrylamide gel system (20) as pre-
viously described (25).
RESULTS
Isolation of MTX-resistant variants. HeLa
BU25 cells previously grown in the absence or
presence of BUdR (25 ,ug/ml) were exposed to
2 x 10-8 or 5 x 10-8 M DL-MTX in BUdR-free
(-BUdR) or BUdR-containing (+BUdR) medi-
um, respectively; similarly, VA2-B cells were
treated with either 5 x 10-8 or 1 x 10-7 M DL-
MTX. Almost all of the cells treated with the
above concentrations of MTX died in the first 2
weeks. Four colonies of BU25 (-BUdR) cells
and four colonies of BU25 (+BUdR) cells resis-
tant to 2 x 10-8 M DL-MTX, four colonies of
BU25 (+BUdR) cells resistant to 5 x 10-8 M
DL-MTX, four colonies of VA2-B cells resistant
to 5 x 10-8 M DL-MTX, and four colonies of the
same cell line resistant to 1 x 10-7 M DL-MTX
were picked up by trypsinization 3 weeks after
plating, and each was grown to a large culture.
These clones, designated with a number indicat-
ing the plate and a letter indicating the clone
picked up in each plate (for example, 10A, 10B,
10C, and 10D), were then exposed to increasing
DL-MTX concentrations. Steps corresponding
to two- to fourfold increases in MTX concentra-
tion were used, the final concentration being 1.8
X 10-4 M DL-MTX. Considerable cell death
occurred after each increase; the surviving cells
were grown for several weeks until no obvious
cell death occurred before the next increase in
MTX concentration in the medium was made. In
the course of this process, each variant popula-
tion was often subdivided into subpopulations,
which were exposed to different schedules of
increasing MTX concentrations, being thereaf-
ter maintained separate (designated by a pro-
gressive number following the clone letter desig-
nation, for example, 1OB1, 10B2, 10B3). The
whole process took between 7 and 11 months for
different variants. Eleven variant cell lines, six
derived from BU25 (-BUdR) cells, one derived
from BU25 (+BUdR) cells, and four derived
from VA2-B cells, which had acquired resistance
to 1.8 x 10-4 M DL-MTX, were selected for
further investigation (Table 1). Because of the
continuous changes occurring in the MTX-resis-
tant variants during growth in the presence of
the drug, each variant is designated by its sym-
bol and a subscript indicating the number of
months of exposure to 1.8 x 10-4 M DL-MTX.
Growth characteristics of the MTX-resistant
variants. All variants were found to grow more
slowly in the presence of the drug than the
parental cell lines grew in the absence of the
drug. In particular, in the first few months after
their adaptation to 1.8 x 10-4 M DL-MTX, their
population doubling times varied between 35 h
and more than 70 h. A marked acceleration in
growth rate occurred in the variants after pro-
longed exposure to the drug, their population
doubling time approaching that of the parental
cell lines. The slower growth rate of the MTX-
resistant variants was not due exclusively to the
presence of the drug, as indicated by the obser-
vation that in several MTX-resistant variants, in
the first 3 weeks after removal of the drug, the
rate of cumulative growth was appreciably slow-
er than that of the VA2-B parental cell line,
gradually increasing thereafter.
Levels of DHFR in MTX-resistant and MTX-
sensitive cell lines. All of the MTX-resistant cell
lines analyzed here exhibited an increased
DHFR activity relative to the parental MTX-
sensitive cell lines (Table 1). The increase in
DHFR levels in MTX-resistant variants, as mea-
sured within the first 10 months after their
adaptation to 1.8 x 10-4 M DL-MTX, varied
between about 35 and 275 times the levels found
in the corresponding parental cell lines. It is
interesting that a great variation in DHFR activi-
ty was observed also among sublines derived
from the same original MTX-resistant clone
(compare, for example, 7D2 and 7D3).
That the increase in DHFR activity in the
MTX-resistant variants analyzed here reflected
an increase in enzyme protein was shown by an
electrophoretic analysis of the cell extracts.
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TABLE 1. DHFR activity and chromosome constitution of MTX-sensitive and MTX-resistant cell lines
No. of days for decay
DHFR of DHFR activity in Chromosome constitution'
actvit Relative MTX-free mediumCell linea activity DHFR(U/mg of activit No. of No. of double
protein) Y To 50% To 20% Complementc chromosomes/ minutes per
ceild celle
Parental
HeLa BU25
(-BUdR)
Variants
10B11
1OB21
10B33
loci
1OC21
10C34
Parental
HeLA BU25
(+ BUdR)
50.5 ± 14.7 1 iS (100)
11,500 228 13 33 iS (100)
9,100 180 21 38 21S (95)
iS (97)
13,800 273 16 31 21S (3)
1S (73)
5,400 107 14 21 2S (24)
3S (3)
5,200 103 47 86 2s (819)
1S (8)
5,400 107 11 27 2S (89)
4S (3)
45.8 ± 7.2 1S (88)2S (12)
Variant
14D, 9,600 210 12 49 iS (100)
59 t 1
57 t 2
58 ± 3
93, 111
57 ± 4
113
55 ± 1
106 ± 5
166
55 ± 5
112 ± 3
56 + 2
110 ± 5
210
58 ± 1
109 + 6
56 ± 2
Parental
WI-18 VA2-B
Variants
6A28
6A32
7D210
7D32
79.3 ± 5.9 1 1S (97)2S (3)
11,300 142 8 20 2S (3)7)
7,300 92 34 (18)f 240 (39)f 1S (94)2S (6)
68 ± 2
136
58 ± 2
115
56 ± 1
106, 112
11,400 144 18 90 2S (100) 118 ± 5
2,600 33 29 49 2S (100) 122 ± 5
<0.3
182 (34-841)
154 (42-391)
98 (2-261)
120 (9-348)
a The subscripts in the symbols of the variants refer to the time when the analysis of DHFR activity was
carried out.
b A total of 32 to 40 metaphase spreads were analyzed from each cell line within the first 6 months of
maintenance in the presence of 1.8 x 10-4 M DL-MTX.
Numbers within parentheses indicate the percentage of cells in each category.
d Average + standard deviation. Whenever only one or two metaphases were found in a given group, the
individual values are reported.
e Since it was often difficult to identify the pairs of double minutes, especially when present in clusters, and
since many of these elements appeared to be unpaired, the values reported here represent the mean and range of
numbers of individual minutes per cell. From 45 to 74% of these minutes in different cell lines were in clearly
recognizable pairs.
f The numbers within parentheses represent the number of days calculated after subtracting the contribution of
the relatively stable DHFR fraction to the individual values of overall DHFR activity (see Fig. 6B).
When equal amounts of protein were run
through sodium dodecyl sulfate-polacrylamide
gels, a band corresponding to a polypeptide with
an Mr of -22,000 comigrating with the purified
DHFR (25) was observed in the extracts from
the MTX-resistant variants, but not in those
from the MTX-sensitive parental cell lines (Fig.
1). The extracts from 10C2 and 10C3 cells exhib-
ited a band corresponding to DHFR which was
clearly less pronounced than expected from
0.5 (0-6)
19 (0-132)
28 (0-130)
7 (0-42)
75 (4-257)
73 (5-265)
219 (46-475)
<0.3
26 (0-100)
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their degree of resistance to MTX and from their
DHFR activity (Table 1).
Behavior of increased DHFR activity in the
MTX-resistant variants in the absence of MTX.
All of the MTX-resistant cell lines, at the time
when they were analyzed (within the first 10
months after their adaptation to 1.8 x 10-4 M
DL-MTX), were unstable in the absence of MTX
(Fig. 2 and Table 1); in fact, they gradually lost
all or, in one case, most of their excess DHFR
activity over periods ranging in different vari-
ants between 25 and 200 days. The cell line 6A3
was unique in that it showed a biphasic loss of
the excess DHFR activity: this declined to about
30% in 50 days, and thereafter decreased only
very slowly to reach -10% in 400 days.
The loss of DHFR activity in the MTX-resis-
tant variants in the absence of selection was
accompanied by the loss of drug resistance.
Thus, 10B3 cells which had been adapted to
grow in the presence of 1.2 x 10-4 M DL-MTX
(DHFR specific activity of 10.4 x 103 U/mg of
protein) and were then maintained in the ab-
sence of the drug for 7 weeks (during which time
the DHFR activity had dropped to -17% of the
original value) gave only 0.3% survivors when
challenged again with 1.2 x 10-4 M DL-MTX.
These survivors showed the same level of en-
C b c d e f g
BSA-
CA-'
Chyg-O
zyme activity and, upon removal of the drug, the
same degree of instability of MTX resistance as
the original variants (Fig. 2).
Chromosome constitution. An analysis of the
chromosome constitution of the MTX-resistant
variants again revealed a marked variability. As
illustrated in Table 1 and Fig. 3 and 4, which
present the results of an analysis carried out
within the first 6 months of maintenance of the
variants in the presence of 1.8 x 10-4 M DL-
MTX, some cell lines exhibited predominantly a
number of chromosomes close to that of their
parental line, and others exhibited predominant-
ly a duplicated number of chromosomes. This
variability in chromosome number was also ob-
served among sublines derived from the same
original clone, as can be seen for the 10C sub-
lines. One interesting observation is that, in all
cases where no duplication of the chromosome
complement occurred, the modal number of
chromosomes in the MTX-resistant variants was
lower than in the corresponding parental line
(Table 1 and Fig. 3 and 4).
The most striking feature of the chromosome
constitution of the MTX-resistant variants was
the presence of double minute chromosomes,
small, acentromeric chromosomal elements,
which were absent or very rare in the parental
hi j k m n
I A * -
-
-O_ -O-DHFR
RNase A-N
Cyt. c--
FIG. 1. Electrophoretic patterns in sodium dodecyl sulfate-polyacrylamide gel of the cell extracts from the
parental lines and from the eleven MTX-resistant variants described in this work. Lanes: a, BU25 (-BUdR); b,
BU25 (+BUdR); c, 1OB1; d, 10B2; e, 10B3; f, 1OC1; g, 10C2; h, 10C3; i, 14D;j, 6A2; k, 6A3; 1, 7D2; m, 7D3; n,
VA2-B.
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FIG. 2. Quantitative behavior of the DHFR activity of the MTX-resistant variants after removal of the
selective pressure. The curve designated 10B3-R+ refers to partial revertants of 10B3 cells resistant to 1.2 x
lo-4 M DL-MTX which had been maintained for 7 weeks in drug-free medium and which had then survived
reexposure to the same concentration of the drug. See text for details. The curve designated 10B33 refers to cells
resistant to 1.8 x 1O-4 M DL-MTX; an identical curve was obtained for cells resistant to 1.2 x 10-4 M DL-MTX.
cell lines (Table 1 and Fig. 3, 4, and 5). As
indicated by their name, the minute chromo-
somes appeared typically in pairs, though the
distance between the members of each pair was
highly variable; furthermore, the minute chro-
mosomes frequently appeared as unpaired ele-
ments. In this paper, we refer to the minute
chromosomes, whether single or in pairs, as
double minute chromosomes or double minutes,
although for quantitative purposes the minute
chromosomes have been counted individually.
They varied considerably in size and stainability
with orcein. The predominant size and stainabil-
ity of the double minutes of the individual cell
lines tended to be reproducibly different (com-
pare, for example, the double minutes of the 6A3
[Fig. SD], 10C3 [Fig. SE], and 7D3 [Fig. SF]
cells).
The number of double minute chromosomes
varied greatly among different MTX-resistant
variants, even among sublines. Some variants
(lOB1, 1OB2, 10B3, and 14D) exhibited a rela-
tively small average number per cell of recogniz-
able double minutes (8 to 26) (Fig. 3 and 5C); in
these variants, an analysis of the distribution of
the number of these elements per cell in each
cell population revealed very wide fluctuations,
from 0 to more than 100 per cell (Table 1). Other
variants (10C3, 6A2, 6A3, and 7D3) had a large
average number of double minutes per cell (120
to 220) (Fig. SD, SE, and SF); others (10C1, 10C2
and 7D2) had an intermediate number. In both
cases there was again a wide range of values in
each cell population (Table 1 and Fig. 3 and 4).
An examination of Table 1 shows the absence of
any correlation in the various MTX-resistant
variants between the average number of double
minutes per cell and either the level of DHFR
14D,
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35 average number of double minute chromosomes
dropped from 150 to 59. These cells were then
30 tested for the behavior of the DHFR activity and
the number of double minute chromosomes
25 upon further growth in the absence of MTX.
Both DHFR activity and the number of double
-20 minutes declined progressively over the next 100
days (Fig. 6A). However, the kinetics of loss of
enzyme activity, which paralleled that observed
15 in cells grown on plates (Fig. 6A), differed
significantly from the kinetics of loss of double
0 minute chromosomes, which was likewise simi-
lar to that observed in cells grown on plates
5 (data not shown). As mentioned above, the
observed loss of DHFR activity from 6A3 cells
was biphasic, with a phase of rapid loss superim-
z posed upon a slow loss (Fig. 2). When the
contribution of the slow decrease was subtract-
ed from the individual values of DHFR activity,
the resulting curve, which represented only the
5 rapid loss of DHFR activity, showed an excel-
lent agreement with the kinetics of loss of double
minute chromosomes (Fig. 6B). One could cal-
culate in this experiment that for every minute
o chromosome lost there was a decrease of about
80 U of DHFR activity.
5
IC
FIG. 3. Frequency distribution of number of chro-
mosomes and number of double minutes per cell in the
parental line BU25 (-BUdR) and its MTX-resistant
derivatives 10B3, 1OC1, and 10C3. The arrow pointing
to the ordinate axis in the uppermost right panel
indicates the number of cells with no double minutes.
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activity or the degree of instability of the in-
creased DHFR level upon removal of MTX.
Thus, the variants 1OB1, 10B2, and 10B3 had a
much smaller number of identifiable double min-
ute chromosomes than did the 10C2 and 7D2
variants, yet they lost their excess DHFR activi-
ty much faster. The line 10C3 had three times as
many double minutes as the line 1OC1, yet they
lost their excess DHFR activity at the same rate.
Correlation of loss of double minute chromo-
somes and loss of DHFR activity upon removal of
MTX. In mouse cell lines with unstable MTX
resistance, a phenotype which in these cell lines
appears to be correlated with the presence of
double minute chromosomes, removal of the
selective pressure leads to the loss of the double
minutes (17). The same observation has been
made here in the human MTX-resistant variant
6A3. When a suspension culture of these cells
was grown for 6 days in the absence ofMTX, the
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FIG. 4. Frequency distribution of number of chro-
mosomes and number of double minutes per cell in the
parental line VA2-B and its MTX-resistant derivatives
6A2, 6A3, 7D2, and 7D3.
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FIG. 5. Representative orcein-stained metaphase spreads from the BU25 (-BUdR) (A) and VA-B (B)
parental cell lines and from the MTX-resistant variants 1OB1 1I (C), 6A34 (D). 1OC34 (E), and 7D34 (F).
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FIG. 6. Quantitative behavior of the DHFR activity and number of double minute chromosomes per cell in
the variant 6A3 after removal of the selective pressure. (A) Original data pertaining to cells grown in two spinner
cultures and on plates. (B) DHFR data for one spinner culture, corrected by subtracting the contribution of the
relatively stable DHFR fraction. See text for details.
DISCUSSION
In the present work, all the human cell vari-
ants isolated for their resistance to 1.8 x 10-4 M
DL-MTX exhibited a greatly increased DHFR
activity. Work reported elsewhere (C. Morandi,
J. Masters, M. Mottes, and G. Attardi, J. Mol.
Biol., in press) has revealed a large increase in
the amount of DHFR-specific mRNA in the
several variants which have been analyzed, de-
rived from both the VA2-B and the HeLa BU25
parental lines. Furthermore, a genomic analysis
of the 6A3, 7D3, and 10B3 cell lines, using
probes derived from cloned DHFR cDNA, has
shown a large increase in DHFR-specific DNA
sequences as compared to the parental lines
(unpublished observations). Therefore, it seems
reasonable to conclude that a DHFR gene ampli-
fication has occurred in the human variants
investigated here.
Although the resistance to high levels of MTX
and the underlying basic mechanism appeared to
be a common denominator of all of the variants
investigated here, a striking diversity in growth
behavior, relative level of DHFR activity or
DHFR protein, chromosomal constitution, and
degree of instability of the phenotype in the
absence of selective pressure was observed
among the various resistant cell lines analyzed in
the first 10 months after their isolation and even
among the sublines deriving from the same origi-
nal MTX-resistant clones. Another aspect of the
variability observed in the properties of the
human MTX-resistant cell lines was the dynamic
character of the changes detected, which was
most obvious in their growth behavior and in
their chromosome constitution.
In the cell lines 10C2 and 10C3, the detectable
amount of DHFR protein was reproducibly
much lower than that found in other variants
exhibiting a similar increase in DHFR activity;
this observation may indicate the occurrence in
these variants of a structural gene mutation
resulting in a protein product with a reduced
affinity for MTX and an increased specific activ-
ity.
No completely stable MTX-resistant human
variant has been found so far, in contrast to what
has been reported for mouse and hamster cell
lines. Although we have only limited data on this
point, it does not seem that the above-mentioned
difference merely reflects the fact the variants
analyzed here represent relatively recent iso-
lates. In fact, two of the variants (6A2 and 7D2),
which were examined after 8 to 10 months of
growth in the presence of 1.8 x 10-4 M DL-
MTX, exhibited an instability of phenotype
comparable to that of the other variants. In some
of the mouse MTX-resistant cell lines previously
investigated by others, stability of the pheno-
type has been shown indeed to arise during
prolonged growth in selective medium (17);
however, other mouse and Chinese hamster cell
lines have exhibited a stable resistance to the
drug very early after their isolation (10, 26).
The most striking alterations observed in the
variant cell lines analyzed here are the anoma-
lies found in their chromosome constitution.
These anomalies involved a change in chromo-
some number and the presence of double minute
chromosomes. A third type of alteration, i.e.,
the appearance in one or more identifiable chro-
mosomes of some variants of a homogeneously
staining region (HSR) containing DHFR genes,
analogous to that described in Chinese hamster
and mouse MTX-resistant cell lines with stably
amplified DHFR genes (7, 10, 26), will be de-
scribed elsewhere (H. Gay, B. Maurer, and G.
Attardi, manuscript in preparation).
The occurrence of a duplicated set of chromo-
somes in most cells of the population, as has
been observed here in some of the MTX-resis-
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tant variants, has not been reported previously
in MTX-resistant cell lines. It seems likely that
this chromosome duplication event, which oc-
curred during the development of the resistance
to MTX, conferred an advantage upon the cells
undergoing it by rapidly doubling the DHFR
gene complement and therefore, presumably,
the cell content in DHFR. Consistent with this
interpretation is the observation that, in variants
with a duplicated set of chromosomes, the chro-
mosome(s) containing an HSR is present in
duplicate (Gay et al., in preparation).
All MTX-resistant variants investigated here
exhibited the presence of double minute chro-
mosomes. Such small, acentromeric elements
have been described previously in many experi-
mental and human tumors (for references, see
references 3 and 21), where they are relatively
stable in the absence of any known selective
pressure. Recently, it has been reported that the
double minutes from a mouse adrenocortical
tumor contain amplified DNA sequences (14).
Furthermore, the presence of double minutes
has been described in several MTX-resistant
mouse cell lines, and evidence has been present-
ed strongly suggesting that these elements con-
tain amplified DHFR genes (26). In the present
work, the observation of a parallel loss of double
minute chromosomes and DHFR activity in the
variant 6A3 is likewise consistent with the idea
that, in this variant, such elements contain
DHFR genes. Preliminary in situ hybridization
experiments with a high-specific-activity probe
derived from cloned DHFR cDNA have provid-
ed direct evidence of the presence of DHFR-
coding sequences in double minute chromo-
somes from several MTX-resistant human
variants (B. Maurer, unpublished observations).
We do not know whether and to what extent the
differences in size and stainability with orcein of
the double minute chromosomes observed in
cells of different human variants and among cells
of the same variant and within the same meta-
phase can be accounted for by a variability in
chromosome condensation. However, the re-
producibility of the differences detected in the
appearance of double minutes in the various
resistant cell lines suggests the possibility that
the amount of DNA can vary among different
minutes. Such differences in DNA content may
conceivably reflect a variation in the size or
number (or both) of the amplified units con-
tained in each minute. On the other hand, the
observation that the double minute chromo-
somes vary greatly in number in different vari-
ants having a comparable degree of DHFR gene
amplification (as estimated from the increase in
DHFR activity [present work] and the increase
in DHFR mRNA and DHFR specific sequences
in the genome [unpublished observations]) with
no obvious inverse relationship between their
number and their size or stainability suggests
that there must be another set of DHFR genes,
representing a varied portion of the total, which
is associated with the regular chromosomes.
Recent observations indicate that, in some, but
not all, variants, these chromosomal genes are
located in HSRs associated with identifiable
chromosomes (Gay et al., in preparation).
In previous studies on mouse MTX-resistant
cell lines, the instability of the resistance in the
absence of selective pressure has been found to
be associated with the presence of double min-
ute chromosomes; furthermore, in subpopula-
tions of these unstable cell lines, a rough propor-
tionality has been observed between the number
of double minutes and the number of amplified
DHFR genes (26). More recently, in uptake
mutants of neuroblastoma cells, unstable drug
resistance has also been correlated with the
presence of double minute chromosomes (4). It
has been hypothesized that, in the above-men-
tioned cell lines, unequal distribution of the
double minutes at cell division and selective
growth advantage for cells with lower numbers
of these elements would account for the instabil-
ity of the phenotype (17). The observations
made in the present work may point to a more
complicated situation in the human MTX-resis-
tant variants. In fact, the average number of
identifiable double minutes per cell in these
variants has been found to be totally unrelated to
the rate of loss of the excess DHFR activity in
the absence of MTX. Our data suggest that
instability of MTX resistance may also be asso-
ciated with a chromosomal localization of the
amplified units, and depend on a particular sus-
ceptibility of these chromosomal genes to be
lost. Preliminary observations indicate that the
presence of these unstable chromosomal genes
in the human MTX-resistant variants is not
obligatorily correlated with the occurrence of
morphologically recognizable HSRs. An insta-
bility of MTX resistance associated with a re-
duction in size of the HSR present in an identifi-
able chromosome has been reported in a
hamster cell line (J. L. Biedler and B. A. Speng-
ler, J. Cell Biol. 70:117a, 1976).
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